Everyone's focused on (https://www.marketwatch.com/story/why-micron-and-other-major-chip-stocks-are-falling-even-as-the-rest-of-tech-holds-up-506851dc?mod=mw_rss_topstories) and tariffs hitting banks, but healthcare is quietly getting repriced. Defensive sectors with long-duration cash flows were supposed to be safe havens—except the 10-year just broke 5% and duration is the enemy. JNJ, UNH, all the big pharma names trade on normalized multiples *because* people assumed rates stayed low.

Research these companies